The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

SERUM TOXICITY IN VARIOUS PSYCHIATRIC DISORDERS

Published Online:https://doi.org/10.1176/ajp.116.4.309

The serum of schizophrenic, alcoholic, and mongoloid patients had no inhibiting effect on the respiratory activity of surviving rat brain. The serum of patients treated with chlorpromazine enhanced the respiratory activity. A slight tendency to elevated values found in recently admitted schizophrenic adults who were not taking chlorpromazine may be due to prior medication before admission. Phenylketonuric serum depressed brain oxidations, though a similar effect was induced by racemic phenylalanine in concentrations above 40 mg.% as well as by other essential amino acids. It has been suggested that the depressant action of various amino acids may be due not to a direct effect of the amino acids, but to aldehyde formation. It has also been known for a long time that a number of toxic amines such as tyramine, phenylethylamine, mescalin, indole and skatol, all inhibit brain oxidations.

The observed phenomenon may explain the general depression of brain oxidations found in vivo in phenylketonuria by Himwich and Fazekas. The low cerebral matabolic rate found in mongoloid children in vivo by these authors may be due to the brain pathology associated with the condition.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.